Corpus Intelligence Market Analysis — MAIMONIDES MEDICAL CENTER 2026-04-26 09:55 UTC
Market Analysis — MAIMONIDES MEDICAL CENTER
NY market | 13 hospitals | HHI: nan (Competitive)
🛡️ Public data only — no PHI permitted on this instance.
13
Hospitals in Market
6,120
Total Beds
$6.2B
Market Revenue
Competitive
HHI: nan
Narrow
Moat Rating (7/10)
#1
Market Share Rank

Competitive Moat (Mauboussin Framework)

Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).

Scale Advantagemoderate
Switching Costshigh
Market Share19.3%
Top 3 Concentration46.9%
Network Density0.21
Margin vs Market+15.8%
Bed Util vs Market+19.6%

What This Means

This hospital has a narrow moat — narrow moat — some competitive advantages, but vulnerable to new entrants. The NY market is competitive — many players, value creation must come from operations not market power (HHI: nan).

Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full NY market.

Top Competitors

HospitalBedsRevenueRev ShareBed Share
NYC HEALTH+HOSPITAL/KINGS COUNTY381$1,027M16.5%6.2%
BROOKDALE HOSPITAL MEDICAL CENTER498$692M11.1%8.1%
NEW YORK-PRESBYTERIAN/BROOKLYN METHO516$658M10.6%8.4%
NYC HEALTH + HOSPITAL / SOUTH BROOKL252$589M9.5%4.1%
WOODHULL HOSPITAL CENTER238$530M8.5%3.9%
THE BROOKLYN HOSPITAL CENTER257$403M6.5%4.2%
UNIVERSITY HOSPITAL OF BROOKLYN305$363M5.8%5.0%
WYCKOFF HEIGHTS MEDICAL CENTER240$320M5.1%3.9%
KINGSBROOK JEWISH MEDICAL CENTER2342$189M3.0%38.3%
INTERFAITH MEDICAL CENTER153$136M2.2%2.5%

Regional Payer Mix

■ Medicare 21%■ Medicaid 13%■ Commercial 66%